Wick Capital Partners’s Boston Scientific BSX Stock Holding History

Wick Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,387	Closed	-$275K	–	254
2026 Q1	$275K	Buy	+4,387	New	+$351K	0.05%	163

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wick Capital Partners's BSX Position: Q2 2026 in Review

Wick Capital Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,387 shares — an estimated $275K sold.

Wick Capital Partners first reported a position in BSX in Q1 2026 and held it in 1 quarter. The position peaked at $275K in Q1 2026. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Wick Capital Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Wick Capital Partners sold 4,387 Boston Scientific shares in Q2 2026, an estimated $275K.
Wick Capital Partners first reported a position in Boston Scientific in Q1 2026 and held it in 1 quarter.
Wick Capital Partners's Boston Scientific position peaked at $275K in Q1 2026.
1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wick Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.